Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
PaperCitations, authors & open-access status
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 234 citations, 2023 year and closed oa status.
234
Citations
2023
Year
closed
OA Status